Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”
Titel:
Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”
Auteur:
Shi, Y. Wu, L. Yu, X. Xing, P. Zhou, J. Wang, A. Shi, J. Hu, Y. Wang, Z. An, G. Fang, Y. Sun, S. Zhou, C. Wang, C. Ye, F. Li, X. Wang, J. Wang, M. Liu, Y. Zhao, Y.